This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Sandoz Ag. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Johann Bacher: Innovator in Pharmaceutical Composition
Introduction
Johann Bacher is a notable inventor based in Kundl, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable pharmaceutical compositions. His work has implications for the treatment of various medical conditions, showcasing the importance of innovation in healthcare.
Latest Patents
Johann Bacher holds a patent for a stable pharmaceutical composition containing 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione or a pharmaceutically acceptable salt thereof. This invention relates to a stable pharmaceutical composition comprising amorphous or crystalline linagliptin or a pharmaceutically acceptable salt of linagliptin, mannitol, copovidone, and magnesium stearate. The patent also includes processes for preparing the stable pharmaceutical composition and a container comprising the stable pharmaceutical composition.
Career Highlights
Johann Bacher is associated with Sandoz AG, a global leader in generic pharmaceuticals and biosimilars. His work at Sandoz AG has allowed him to contribute to the advancement of pharmaceutical sciences and improve patient outcomes through innovative drug formulations.
Collaborations
Throughout his career, Johann has collaborated with esteemed colleagues such as Franz Xaver Schwarz and Georg Anker. These collaborations have fostered a productive environment for innovation and have led to significant advancements in pharmaceutical research.
Conclusion
Johann Bacher's contributions to the field of pharmaceuticals exemplify the critical role of inventors in advancing healthcare solutions. His patent for a stable pharmaceutical composition highlights the importance of innovation in developing effective treatments.